• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About Us
    • Our Attorneys
    • Our Staff
      • Sheila Chavez
      • Marin Gorman
    • Mission Statement
    • Community Service
    • Charities We Support
    • Secret Settlements – Our Stand
    • Patrick Malone & Associates Offers Scholarship to Law Students for Representing Real People
  • Attorneys
    • Patrick Malone
    • Daniel C. Scialpi
    • Alfred Clarke
    • Heather J. Kelly
    • Aaron M. Levine, Of Counsel
    • Peter R. Masciola, Of Counsel
  • Focus Areas
    • Medical Malpractice
      • Hospital Errors
      • Cancer Misdiagnosis
      • Diabetes
      • Kaiser HMO Malpractice
      • Military Malpractice
      • Hospital Security Misconduct
    • Brain and Spinal Cord Injuries
      • Brain Injuries From Medical Care
      • Lead Poisoning
      • Traumatic Brain Injury (TBI)
      • TBI Long-Term Care & Rehabilitation
    • Baby & Child Injuries
      • Birth Injuries
      • Infant/Child Brain Injuries
      • Shaken Baby Syndrome
      • Pediatric Anesthesia Errors
      • Jaundice/Kernicterus
      • Bacterial Meningitis
    • Sex Abuse of Children and Youths
      • Sexual Abuse Claims in Washington D.C.
    • Auto, Truck, and Motorcycle Accidents
      • Car Accidents
        • Maryland Car Accidents
        • Virginia Car Accidents
      • Truck Accidents
      • Motorcycle Accidents
      • Pedestrian Accidents
      • Bicycle Accidents
      • Train Accidents
    • Defective & Dangerous Products
    • Dangerous Drugs
      • Carbon Monoxide Poisoning
    • Nursing Home Neglect and Abuse
    • Consumer Rights
    • Accounting and Legal Malpractice
      • How To Sue Your Lawyer For Malpractice
      • Common Legal Malpractice Claims
      • Damages For Legal Malpractice
      • Missing The Deadline For A Lawsuit
  • Success
    • Verdicts & Settlements
    • What Our Clients Say
    • True Stories
  • Publications
  • Resources
    • Frequently Asked Questions
    • Steps in the Legal Process
    • The Jury Trial System
    • Legal Deadlines for Filing Your Personal Injury Lawsuit
    • Better Health Care Newsletter from Patrick Malone
    • Sign Up for Our Free Newsletter on Getting Better Health Care
    • Free Fact Kit for Injury Victims
    • Tips for Patient Safety and Better Health Care
    • Health Care Advocates’ Power Kit
    • For Attorneys
    • More Legal Resources
    • Fellow Inner Circle Members
    • DC Hospital Ratings Map
    • Motor Vehicle Accident Blog
    • Washington D.C. Bike Map
    • Commute Risk Calculator
  • Patient Safety Blog
    • ProtectPatientsBlog.com
  • Malpractice A-Z
  • Contact Us

Patrick Malone Law

Medical Malpractice & Personal Injury Law Firm | Patrick Malone Law

CALL US TODAY:

202-742-1500
888-625-6635

Are You A Lawyer Seeking Co-Counsel ?
  • About Us
    • Our Attorneys
    • Our Staff
      • Sheila Chavez
      • Marin Gorman
    • Mission Statement
    • Community Service
    • Charities We Support
    • Secret Settlements – Our Stand
    • Patrick Malone & Associates Offers Scholarship to Law Students for Representing Real People
  • Attorneys
    • Patrick Malone
    • Daniel C. Scialpi
    • Alfred Clarke
    • Heather J. Kelly
    • Aaron M. Levine, Of Counsel
    • Peter R. Masciola, Of Counsel
  • Focus Areas
    • Medical Malpractice
      • Hospital Errors
      • Cancer Misdiagnosis
      • Diabetes
      • Kaiser HMO Malpractice
      • Military Malpractice
      • Hospital Security Misconduct
    • Brain and Spinal Cord Injuries
      • Brain Injuries From Medical Care
      • Lead Poisoning
      • Traumatic Brain Injury (TBI)
      • TBI Long-Term Care & Rehabilitation
    • Baby & Child Injuries
      • Birth Injuries
      • Infant/Child Brain Injuries
      • Shaken Baby Syndrome
      • Pediatric Anesthesia Errors
      • Jaundice/Kernicterus
      • Bacterial Meningitis
    • Sex Abuse of Children and Youths
      • Sexual Abuse Claims in Washington D.C.
    • Auto, Truck, and Motorcycle Accidents
      • Car Accidents
        • Maryland Car Accidents
        • Virginia Car Accidents
      • Truck Accidents
      • Motorcycle Accidents
      • Pedestrian Accidents
      • Bicycle Accidents
      • Train Accidents
    • Defective & Dangerous Products
    • Dangerous Drugs
      • Carbon Monoxide Poisoning
    • Nursing Home Neglect and Abuse
    • Consumer Rights
    • Accounting and Legal Malpractice
      • How To Sue Your Lawyer For Malpractice
      • Common Legal Malpractice Claims
      • Damages For Legal Malpractice
      • Missing The Deadline For A Lawsuit
  • Success
    • Verdicts & Settlements
    • What Our Clients Say
    • True Stories
  • Publications
  • Resources
    • Frequently Asked Questions
    • Steps in the Legal Process
    • The Jury Trial System
    • Legal Deadlines for Filing Your Personal Injury Lawsuit
    • Better Health Care Newsletter from Patrick Malone
    • Sign Up for Our Free Newsletter on Getting Better Health Care
    • Free Fact Kit for Injury Victims
    • Tips for Patient Safety and Better Health Care
    • Health Care Advocates’ Power Kit
    • For Attorneys
    • More Legal Resources
    • Fellow Inner Circle Members
    • DC Hospital Ratings Map
    • Motor Vehicle Accident Blog
    • Washington D.C. Bike Map
    • Commute Risk Calculator
  • Patient Safety Blog
    • ProtectPatientsBlog.com
  • Malpractice A-Z
  • Contact Us
Call
Contact
Blog
You are here: Home / Proven and practical ways to slow or prevent cognitive decline

Proven and practical ways to slow or prevent cognitive decline

When we get sick, all too many of us respond reflexively: Ring up the doctor, wolf down some prescribed pills, and everything, we hope and trust, will turn out fine.

That approach is problematic on many levels, especially because it often does not work. Big Pharma may be riding high these days, what with its development of miraculous coronavirus vaccines. But drug makers absolutely have not come up with treatments for all of humanity’s major ills.

This is especially true with dementia and the cognitive condition’s best-known form: Alzheimer’s disease. Sure, the news has been full of reports that the federal Food and Drug Administration just granted an accelerated approval to a prescription medication from Biogen aimed at Alzheimer’s — the first such drug to win such an endorsement in a decade.

But there are huge concerns about this medication, the medical theory underlying it, the research that won its regulatory nod, the process by which it was reviewed — not to mention the drug’s sizable cost, which is certain, and its safety and effectiveness, which are uncertain.

While advocates hope it opens frontiers in dementia treatment, this medication may have another powerful effect: reminding us all that we can do things besides taking drugs that can help delay or prevent debilitating conditions like Alzheimer’s.

Can we think ahead, be savvier, and protect our brains with healthful behaviors? No need to scratch your head as to what’s involved — the figure above provides a map to ideas that experts want all of us in a fast-graying nation to act on to reduce dementia’s burdens.

Don’t be paralyzed by dread of dementia. Here’s how to protect your cognitive health now.
 

Few diseases terrify older people as much as Alzheimer’s does. With reason. It can strip seniors of their memory and cognitive capacity, leaving them incoherent and dazed. It can cause them to grow agitated and to wander aimlessly.

Patients with dementia may lose control of bodily functions and require 24/7 care — much of it, sadly, provided by exhausted spouses and other loved ones. Family members may not only be financially drained by caregiving but also could be subjected to physical struggles with demented loved ones, who may say inappropriate things and act in inexplicable ways.

The burdens of the disease — and the absence of treatments for it — can create despair. Just look at those worrisome national statistics on the illness’s increasing costs and rising incidence (see By the Numbers on right rail).

But is the condition daunting enough so that people will take evidence-based steps to delay or prevent it? Maybe so, experts say, especially because a growing body of research suggests how.

Alzheimer’s and dementia, for now, can be tough for doctors to detect early, diagnose its different forms and causes, and treat it (see sidebar below). There are many theories, specifically about Alzheimer’s origins (more about that in a bit). But many of the evidence-based preventive measures may be familiar, unsurprising, and based in common sense.

Good for the body, good for the brain

In brief, what’s good for the body also can be beneficial to one of its largest and most commanding organs, the brain.

Experts recommend that we protect our cognitive capacities with regular vigorous exercise, as well as a well-balanced, plant-heavy diet — eating that focuses on less fat, sugar, and salt, and that favors fish and nuts over beef and pork. Think of a meal plan built around the popular “Mediterranean” or “DASH” (blood-pressure reducing) diets.

To protect optimal brain health, skip the tobacco smoking and vaping, of course, and go easy on the intoxicants, whether alcohol or substances like marijuana. Older people need to be wary of anticholinergic drugs (including antihistamines and some antidepressants) as well as benzodiazepines (Valium, Xanax for anxiety and sleeplessness). These have been linked to delirium, cognitive impairment, and dementia. Some people need to take these drugs, but they must be aware of the side effects.

We need to manage our weight to protect our hearts and lungs, and work with our doctors to manage our blood pressure (hypertension) and ensure we don’t develop diabetes.

All this advice may sound most on point to those wishing to stay fit and spry. But this advice also addresses challenges that experts know can result in cognitive damage. Research, for example, underscores that vascular and circulatory problems may be the second most common cause of dementia. It often occurs, say, after patients suffer repeated strokes or prolonged and uncontrolled high blood pressure.

Avoiding head trauma

Dementia also can result from physical damage to the brain. Doctors long have identified cognitive declines linked to substance abuse, especially excess consumption of alcohol.

Those who suffer repeated blows to the head — especially in athletics and without protective gear — also can show cognitive impairment that can be a kind of dementia. The harms of concussions are so well-known they have entered the lexicon in phrases like “punch drunk.” Sadly, in our era of hero worship for pro players, we’re also seeing too many stars of yore in boxing, football, and other competitive athletics enter their golden years, if they get there, with mental impairments.

Still, parents and young athletes are showing greater awareness of the risks and long-term perils of concussions and repeated blows to the head. Coaches and organized sports programs are rushing to provide improved protective gear and to avert unnecessary contact to the head in an array of amateur athletics. A billion-dollar settlement the National Football League reached over players’ head and brain injuries also shows that pro leagues may be committing more to protecting their people.

Social engagement and intellectual stimulation

When it comes to safeguarding cognitive function, studies show that keeping the brain at work appears to be important to preventing its decline. It appears to be true that minds can get mushy if left alone and taxed insufficiently.

This can mean that we need to stay socially engaged and keep up robust engagement with friends and loved ones. Recent studies have shown that lack of purpose, loneliness, isolation, and depression take a terrible toll on the spirit, mind, and body. Health workers, caregivers, and family members have, for example, reported major declines in the well-being of residents of nursing homes and other long-term care facilities during lockdowns ordered during the coronavirus pandemic.

Besides social engagement, the brain must be stimulated and challenged to some degree to keep up its optimal state, studies show. A cottage industry has cropped up purporting to offer intellectual stimulation via puzzles, games, and online and video products promoted as “brain exercises” for older adults. The jury’s out on the outcomes generated by, for instance, knocking out a daily crossword puzzle or taking regular online quizzes or courses. Studies haven’t found the major benefits suggested by aggressive advertising and marketing campaigns.

Keep up the sleep, hearing, and vision

Research has pointed out the importance of some lesser-known ways that people can benefit their brains and slow or possibly prevent Alzheimer’s and other forms of dementia: We need to get plenty of sleep. And we need to do all we can to ensure we see and hear well.

Experts will be unraveling the mysteries of sleep for a long time. But well-accepted theories suggest that crucial functions occur in the brain during the time many of us think we just doze. The brain uses our sleep time to process and record our experiences, including cleaning up processes that may have gone awry during the waking hours. We also may transfer temporary perceptions to longer-term memory during sleep. At a biochemical level, the brain may use sleep time to clear out harmful substances, such as the proteins and tangles of them that an influential theory holds may be a cause of Alzheimer’s.

As for our sensory wellness, a growing body of information is telling experts that decreased hearing and vision can trigger significant cognitive declines. When older adults cannot see or hear well, their social and intellectual engagement can plummet, with bad consequences. Because women live longer than men, they may experience greater incidences of hearing and vision impairment and loss that becomes dementia-Alzheimer’s. In fact, over a lifetime, women have twice the risk that men do of developing Alzheimer’s.

Be wise about limits of existing research

Key concepts matter in understanding where we stand in dealing with dementia.

As of now, we lack the big C — a cure or effective treatment.  Don’t be gulled by hucksters who say otherwise, for example, claiming without evidence that dietary supplements work magic on the brain.

If you are confused by experts describing an aggressive search for delaying dementia rather than remedying it, there are good reasons why. The earlier the onset of the disease, the greater its burdens. As mentioned, it can be costly and difficult to care for those with the disease. Putting off the onset as near as possible to the natural end of patients’ lives could be helpful.

Important caveats also need to be made clear about recommended preventive steps, as the Alzheimer’s Association, a leading patient advocacy group, does in its online information:

“Insights about potentially modifiable risk factors apply to large population groups, not to individuals. Studies can show that factor X is associated with outcome Y but cannot guarantee that any specific person will have that outcome. As a result, you can ‘do everything right’ and still have a serious health problem or ‘do everything wrong’ and live to be 100.

“Much of our current evidence comes from large epidemiological studies such as the Honolulu-Asia Aging Study, the Nurses’ Health Study, the Adult Changes in Thought Study and the Kungsholmen Project. These studies explore pre-existing behaviors and use statistical methods to relate those behaviors to health outcomes. This type of study can show an ‘association’ between a factor and an outcome but cannot ‘prove’ cause and effect. This is why we describe evidence based on these studies with such language as suggests, may show, might protect, and is associated with.

“The gold standard for showing cause and effect is a clinical trial in which participants are randomly assigned to a prevention or risk management strategy or a control group. Researchers follow the two groups over time to see if their outcomes differ significantly. It is unlikely that some prevention or risk management strategies will ever be tested in randomized trials for ethical or practical reasons. One example is exercise. Definitively testing the impact of exercise on Alzheimer’s risk would require a huge trial enrolling thousands of people and following them for many years. The expense and logistics of such a trial would be prohibitive, and it would require some people to go without exercise …”

Lest anyone think that the “fine print” cautions about lifestyle and other preventive measures undercuts experts’ enthusiasm for their use in delaying or preventing Alzheimer’s-dementia, they would be mistaken. This has become clearer due to federal regulators’ recent dealings with a prescription drug promoted for Alzheimer’s treatment.

Here’s why a new Alzheimer’s drug has created such anger and confusion

There’s a four-letter word for patients and families who have heard about a new drug for Alzheimer’s and are racing to get their doctors to prescribe it for them — whoa!

Critics have assailed the Biogen drug, brand name Aduhelm, arguing that it provides unfounded hope and too many negative lessons about the search for a safe and effective Alzheimer’s drug.

Aduhelm is Biogen’s answer to a leading medical theory as to the cause of Alzheimer’s: that the protein amyloid clumps into tangles and plaques in the brains of patients and fouls up their cognitive processes. Biogen says that Aduhelm, a monoclonal antibody, helps to clear amyloid from patients’ brains.

But this hypothesis, despite billions of dollars of spending, notably by Big Pharma researchers, has not been proven. Indeed, it is falling into disfavor and without a replacement. That’s because even if Aduhelm and other experimental drugs reduce amyloid in the brain, clinical studies have not shown that this improves or extends patients’ lives.

Federal regulators, though, can give an accelerated approval to prescription drugs based on research on what is known as “surrogate endpoints,” substitute criteria that might include, say, whether a cancer medication shrinks a tumor or seems to delay certain symptoms. That is not the same as more pertinent criteria, such as improving or extending patients’ lives, critics say.

They say Aduhelm is only the latest Big Pharma product that will be costly for patients, families, and taxpayers, with a bit of benefit, at best.

Diagnostic screens and sustained testing

Those racing to get the drug must know that doctors are not supposed to prescribe it casually — say, if older patients want to take it preventatively or if they experience occasional but worrisome memory lapses.

Doctors are supposed to require patients to undergo extensive, invasive, and expensive testing to diagnose them with Alzheimer’s and make them eligible for Aduhelm. This likely would include imaging studies of their heads to see if they show plaque buildups. The screens can cost several thousands of dollars.

And remember, doctors already struggle to differentiate dementia causes — whether by amyloids, vascular problems, brain damage (due to physical shocks or substance abuse), or issues with alpha-synuclein, a protein associated with a Lewy body disorder that also has been tied to Parkinson’s.

If patients get the go-ahead to take Aduhelm, they face further challenges. They must take it monthly as an infusion, typically given over an hour’s time in a doctor’s office, clinic, or hospital. They also must undergo regular and sustained monitoring, including those pricey head scans, because Biogen has warned that its medication can cause brain swelling and bleeding.

Those issues, of course, cropped up when Biogen ran not one but two clinical trials of its drug. After its trials, the drug maker announced it was abandoning the product into which it had sunk huge sums. But it then reexamined and reinterpreted data from its studies, arguing that its after-the-fact analyses showed its drug was useful and should be approved.

The FDA’s independent experts, however, tore apart Biogen’s research and advised the agency — in stark terms — to reject the drug. When their advice was disregarded, members of the elite panel resigned in protest.

Billions of dollars in prospective new costs

Biogen has added insult to injury, critics say, by deciding that it will charge $56,000 annually for Aduhelm. That is far above the $2,500-$8,000 annually that an independent panel of experts had recommended as fair.

Here is the flummoxing part of the drug and its approval: Biogen’s clinical trials focused on Aduhelm’s potential effects on early-stage Alzheimer’s patients. But federal regulators seemed oblivious to this important distinction. They instead have allowed the company to market the drug for at least nine years to all Alzheimer’s patients, with zero evidence of its effects on those with more advanced cases.

Further — and this is the part that affects all of us who pay taxes — the actions by the federal Food and Drug Administration typically now clear the way for Medicare and Medicaid to be required to pay for Aduhelm for seniors if doctors prescribe it. This puts the U.S. Treasury on the hook for billions of dollars in new spending on prescription drugs, just as consumers are howling about medicines’ already skyrocketing costs.

The United States, as things stand now, could spend more on Aduhelm alone than it does for the space agency NASA. (Remember, due to fierce Republican support for Big Pharma, Medicare officials are blocked from negotiating on prescription drug prices.)

The FDA has said that its approval was based partly on the overwhelming need for patients and families to find some ray of hope in Alzheimer’s care. That is a moving reason, but it is not part of the rigorous scientific and regulatory rationale for judging the safety, effectiveness, and cost of prescription drugs. The agency also has said Aduhelm will need further clinical trials because its approval was accelerated and conditional.

Big or small (measured) gains?

Biogen appears as if it will have roughly a decade, though, to sell Aduhelm and to rack up huge profits from it. If this Alzheimer’s drug can squeak by regulators, maybe others of its kind will, too, given the precedent the FDA has set. Will this be viewed in the long term as the agency opening the door to steady advances in dementia treatment with prescription medications, as some groups have suggested? They point to slow FDA oversight on HIV-AIDS treatments that may have delayed progress and cost the lives of far too many. Or will patients and physicians find themselves besieged by tough choices on Alzheimer’s drugs with huge costs and small benefit?

Here’s another key consideration about Aduhelm. As the Associated Press reported on a central measure of the drug’s effects:

“Patients taking [the drug] saw their thinking skills decline 22% more slowly than patients taking a placebo. But that meant a difference of just 0.39 on an 18-point score of cognitive and functional ability. And it’s unclear how such metrics translate into practical benefits, like greater independence or ability to recall important details.”

The long-term care crisis can’t be ignored

The urgency to find safe, effective, and affordable ways to deal with dementia and Alzheimer’s has only accelerated due to yet another costly complication: the rising need for and expense of nursing home and other long-term care for the aged, ailing, and injured.

The prospective demand for such services is huge. As researchers at the Pew Foundation reported, “on this day and for every day [for a decade or so more], 10,000 baby boomers will reach age 65.” While a decade ago, “just 13% of Americans [were] ages 65 and older … [b]y 2030, when all members of the Baby Boom generation have reached that age, fully 18% of the nation will be at least that age.”

Here is what researchers at the independent, nonpartisan RAND Corporation have reported about the stunning burdens individuals and the nation will confront with dementia care:

“A RAND study published in 2013 …. —the most-detailed examination done in recent decades on the costs of dementia — found that dementia already takes a higher economic toll than heart disease or cancer: at least $159 billion a year, and possibly as much as $215 billion. Nearly 15% of Americans older than 70 —some 3.8 million people — already have dementia, the RAND study found. That number will swell to 9.1 million people by 2040, it calculated, more than the current population of New York City. At that point, the cost to care for them could exceed half a trillion dollars a year, according to Michael D. Hurd, the study’s lead author, an economist by training, and director of RAND’s Center for the Study of Aging.

“Even if the rate of dementia slows, as some recent studies suggest it might, the overall number of people getting sick will continue to balloon as the population ages, and with it the costs.”

Problems laid bare by coronavirus pandemic

The coronavirus pandemic exposed the nation’s crisis in nursing homes and long-term care, with roughly a third of diagnosed deaths and tens of millions of infections occurring at institutions housing the vulnerable old.

That has led families to rethink existing facilities, which struggle with huge problems like infection control and inadequate staffing. Studies have shown that the coronavirus ripped through nursing homes, partly because their health workers were overworked, stressed to the max, under-trained, and underpaid.

Nursing homes already charge sky-high rates, with the nationwide average cost for a single bed running around $100,000 annually. “Memory care,” the intensive 24/7 services required by dementia patients, can be some of the priciest long-term care around. Because so many seniors have exhausted their own finances, the federal government has seen its costs head alarmingly northward to pay for seniors’ long-term care.

If you’re younger and haven’t done so, you should sit down with your financial advisor (or maybe the people who help your parents or other older relatives with their money) and assess your saving and other preparation for old age. You should put your mind to the ever-increasing cost of medical services as you age. And you may need to determine not only the status of your retirement accounts but also the utility of long-term-care insurance policies, which may be more affordable if you get one long before you need it.

You may want to be more rigorous about adopting some of the preventive steps outlined above. And you may want to pause and reconsider your views on age and infirmity.

An inflection point?

The whole country could hit a turning point, when we no longer try to make older people disappear, preferring to chase perpetual youth. We are making strides in appreciating how our differences should not divide us but should be seen as strengths and causes for celebration. We’ve got a long way to go in dealing with inequities rooted in race, nationality, gender, and sexual orientation (to name a few of the human characteristics our society is reckoning with).

Friends and loved ones of those with dementia and Alzheimer’s say they can be overwhelmed, not only by the demands of caring for sick loved ones, but also by the stigma that is attached to seniors’ natural decline as they age. We’ve learned to see the joy that young athletes can find in programs like the Special Olympics.

But we get embarrassed, turn away, and shun older adults who venture out in public with their caregivers and act “demented,” or lacking in personal control.

Caregivers can testify that those with cognitive conditions aren’t always unruly or inappropriate. They can have moments of clarity and happiness, as when some Alzheimer’s patients receive music therapies. We need to accord greater dignity to those with cognitive impairment in old age. We can reset our expectations. We must appreciate the incapacitated for who they are and what they can do, not wishing for them to magically be what they once were and what they used to do. We must enjoy our time with all our friends and loved ones and support their caregivers.

Here’s hoping that you’ve gotten helpful ideas about staying mentally and physically fit and well — throughout 2021 and beyond! May you have an old age with remarkable good health, laughter, and love.

With cognitive conditions, diagnosis is not always easy

Person, woman, man, camera, TV … With his recitation of that word list in a televised news conference, the garrulous former President Trump put his own twist on what has become an anxious moment for increasing numbers of people.

It happens when they undergo tests to see if they suffer cognitive decline, potentially linked to dementia and its most common form, Alzheimer’s disease.

Diagnosis of dementia persists as a complex, uncertain part of medicine’s dealing with the condition — partly because many factors must be considered, and, ultimately, because of the reality that doctors may be hunting for unhelpful signs of brain disease.

Patients should know that simple forgetfulness or occasional confusion may not be symptoms of serious long-term cognitive decline, and that the brain does not have to become feeble with age. But if individuals and those who know them well see mental acuity problems in an older adult, a full health workup will consist of many ways to detect, say, dementia.

The doctor typically will take or study the patient’s medical history, as well as perform a physical and order blood tests for infections and to check levels of chemicals, hormones, and vitamins.

The medical sleuthing will zero in on issues such as what medicines patients may be taking, whether they have a family history of dementia-Alzheimer’s, and whether they have aggravating conditions like diabetes, high blood pressure, substance abuse, HIV-AIDS, or hearing loss.

Doctors will perform neurological tests, too, such as an assessment of patients’ balance, sensory response, reflexes, and other cognitive functions. If appropriate, your doctor, especially in consultation with a neurologist, may order brain scans to “identify strokes, tumors, and other problems that can cause dementia” federal experts say. “Scans also identify changes in the brain’s structure and function.”

Patients may undergo computed tomography (aka a CT scan, which uses x rays to produce images of the brain and other organs), magnetic resonance imaging (MRI, which uses magnetic fields and radio waves to produce detailed images of body structures, including tissues, organs, bones, and nerves) or positron emission tomography (PET scan, which uses radiation to provide pictures of brain activity).

Because depression and other mental health issues may affect cognitive functions, patients may undergo psychiatric evaluation. They may take genetic screenings to determine if they are predisposed to known disorders affecting brain health.

Yes, they also may undergo cognitive screening, notably the Montreal Cognitive Assessment, widely known as the MoCA test. Trump talked about his screen to make a political point about his mental sharpness, especially as he claimed it showed him to be in better shape than Joe Biden, the (also) 70-something Democratic candidate who defeated him.

But Trump’s absurd reduction of his test — essentially as repeating recalled terms — concerned experts. They emphasized that the MoCA test, and others like it, is much more than parroting, and no one should take it or other similar exams lightly, as the Washington Post reported, noting:

“[F]or many Americans, the test Trump keeps trumpeting is one of the most fraught, traumatic turning points in their lives — that moment when they realize their mind is beginning to fail and glimpse the troubled path ahead for them and their families.”

Cognitive assessments, especially purported memory checkups featuring lists of words and items, have become common online, leading to experts’ caution about using and interpreting results from such screens.

Healthy skepticism exists, too, about claims of advances with quicker, easier, and faster blood testing for Alzheimer’s.

The New York Times reported that experts believe they are nearing a better way to screen and diagnose the illness using the blood, rather than current “expensive methods like PET scans of the brain and spinal taps for cerebrospinal fluid.” As reporter Pam Belluck wrote:

“The [new blood] test has the potential to make diagnosis simpler, more affordable and widely available. The test determined whether people with dementia had Alzheimer’s instead of another condition. And it identified signs of the degenerative, deadly disease 20 years before memory and thinking problems were expected in people with a genetic mutation that causes Alzheimer’s, according to research published in JAMA and presented at the Alzheimer’s Association International Conference.

“Such a test could be available for clinical use in as little as two to three years, the researchers and other experts estimated, providing a readily accessible way to diagnose whether people with cognitive issues were experiencing Alzheimer’s, rather than another type of dementia that might require different treatment or have a different prognosis. A blood test like this might also eventually be used to predict whether someone with no symptoms would develop Alzheimer’s.”

While Belluck provides due cautions in her news story, and the researchers reporting on their work do, too, the public should be skeptical about developments in Alzheimer’s and other complex medical conditions, warned Gary Schwitzer. He was the founder and publisher of the respected but now defunct HealthNewsReview site and a onetime journalist who has covered health care for decades. He decried in an online post on his site the hype others spent on the Alzheimer’s blood test:

“Today’s news about a ‘breakthrough’ test is certainly not the first we’ve heard like that about a possible Alzheimer’s test. On Twitter, former hedge fund manager and TV personality Jim Cramer called it a “major game changer.” Dr. Oz called it a “major breakthrough.” The New York Times headlined its story, ‘Amazing, Isn’t It?’ Long Sought Blood Test for Alzheimer’s in Reach.”

He said he went through his files and easily found multiple times when developments with the disease were heralded but then disappointed. This may be due to medical scientists’ over-reliance on theories about Alzheimer’s origins with an excess in the brain of the amyloid protein. Despite billions of dollars and years of study, this idea of the disease’s cause has not proved out, and the theory itself is fading.  

Indeed, as Schwitzer and others have pointed out, a haunting concern about Alzheimer’s-dementia diagnosis is its “so what?” factor. Even if doctors can determine a patient has the condition, absent highly effective therapies to slow or stop its progress, is the diagnosis helpful?

End the silence over terrible, costly burdens borne by caregivers

The conditions of progressive cognitive decline — dementia and its most common form, Alzheimer’s disease — have intensified a crushing, hidden crisis in caregiving.

It will only worsen as the nation grays and forces more friends and families to determine how to take care of loved ones with mental incapacitation.

Here’s a statistical glimpse at America’s typical caregiver, according to a major 2020 study: She’s typically older than 50. For the last 4.5 years, she has devoted 24 hours a week or more without pay to helping to dress, feed, bathe, shop for, and handle the finances of a relative, likely her mom, who typically is 74.8 years old. The person needing care increasingly may live with her. But trying to juggle other responsibilities, including her spouse, children, and a full- or part-time job, is hugely stressful—and it is growing more so.

If this sounds like a tough go, just remember that this is a sketch of the “average” caregiver. One in 10 of them are women 75 or older. They may be devoting 30 unpaid hours or more a week to looking after an even older, sicker spouse. They do so alone. Research shows these women have carried their heavy burdens for more than five years.

Younger Americans also are stepping into these challenging roles, with a third of all caregivers now estimated to be millennial men and women ages 18 to 34.

Caregivers’ toil, with an estimated value of $470 billion annually, occurs too often with too little support, and in too many cases without pay. It harms caregivers’ health, well-being, careers, and finances.

 Research shows that:

 “Family caregivers (age 50 and older) who leave the workforce to care for a parent lose, on average, nearly $304,000 in wages and benefits over their lifetimes. These estimates range from $283,716 for men to $324,044 for women. Evidence suggests that assuming the role of caregiver for aging parents in midlife may substantially increase women’s risk of living in poverty in old age.”

The caregiving crisis may be a drag on the economy as a whole, experts say, especially as women play an increasingly important role in the labor force but are forced from it by caregiving responsibilities.

Meantime, the stress of shouldering what can seem to be the weight of the world can make life unbearably dark for caregivers. Many say they feel like caregiving pushed them off a cliff with no warning. This isn’t something most people plan for. And they have lost control of their lives. Depression. Fatigue. Anxiety. Worry. These are common, and, sadly, little-discussed effects that add up and may even shorten their own lives.

The coronavirus pandemic has underscored the huge burdens that women shoulder in caregiving and running extended households composed of multiple generations. Due to a lack of job flexibility, notably in schedules and the ability to work from home, women suffered harsh and disproportionate job losses (the pandemic created what some economists dubbed a “she-cession”). They have been slow to return to work and to get rehired. They may be considering whether they need to care for an older generation, rather than seeing their dads, moms, and other loved ones struggle and die in nursing homes and other institutions.

The pandemic also has re-energized discussion about “de-hospitalization” — whether  with technological advances and more, it makes greater sense for patients to spend less time in fancy academic medical centers and giant hospitals and more time at home for treatment and recovery. But will health insurers and the federal government pay ordinary folks for stepping up their roles in treating the sick and injured?

President Biden has proposed a major increase in federal support for home care, particularly for seniors, the ill, and the injured. Critics say his financial boost is insufficient, and Republicans in Congress are unlikely to support Biden’s plans.

But individually, as well as collectively in our communities, we can reach out to better support caregivers. You may find your church or social clubs already do so—or you may want to push them to. You also may want to think about your own circle of family and friends: Are there people close to you who may have disappeared from your life because, quietly, they’ve had to step up as caregivers? You may wish to renew contacts and give these overwhelmed folks more than air kisses, please.

AARP, a leading advocacy group for older Americans, offers solid counsel on what you can do, including the good advice to be concrete and specific with offers of help: Don’t just say you’d be happy to assist. Instead, suggest something like: I wonder if I could sit with your mom for an hour on Saturday to give you a break? Or: I know my kids will be going to the same event and wondered if I could spare you an extra trip by ferrying yours?

Recent Health Care Blog Posts

Here are some recent posts on our patient safety blog that might interest you:

  • It’s three strikes now from the U.S. Supreme Court: Have Republicans finally gotten themselves thrown out of their game to strip tens of millions of Americans of their health insurance? The conservative-packed high court, in a 7-2 vote, rejected the latest and third GOP attempt to overturn the Affordable Care Act, which Republicans in Congress also have failed to kill in more than five dozen votes over more than a decade. The case decided by the justices — supported by the Trump Administration and brought by attorneys general in Republican-controlled states like Texas and opposed by their counterparts in Democratic-controlled states — proved to be the legal equivalent of a belly flop. The overpowering majority of the court found that the GOP states lacked even the standing to contest the law. 
  • A rare outbreak of tuberculosis among dozens of surgical patients — some of them at hospitals in northern Virginia — is under investigation by federal health authorities, including the Centers for Disease Control and Prevention.  The CDC  suspects the infections may be tied to a malleable bone putty used in spinal and other orthopedic procedures. The substance includes human cells harvested from cadavers, according to Aziyo Biologics Inc., a regenerative medicine company that has voluntarily recalled 154 containers of its FiberCel product. Patrick Malone & Associates represents patients infected with tuberculosis apparently from this FiberCel bone putty product. Our firm is actively investigating what happened to determine the legal liability of everyone involved and to see where the  breakdowns occurred in the checks and balances intended to keep medical products safe.
  • Poorer communities of color in the region around the nation’s capital are inching toward getting more equitable hospital care — with new facilities slowly coming online to replace decrepit and risky institutions. Politicians and public leaders in Maryland celebrated a decade-long fight to see the opening in Largo of a new hospital,  a “620,000-square-foot, glass-paneled facility [that] will replace the 75-year-old Prince George’s Hospital Center in Cheverly,” the Washington Post reported. The new University of Maryland Capital Region Medical Center, near the Largo Town Center Metro station, had been stalled for years in political and regulatory battles over its size and funding. It will be part of the University of Maryland Medical System’s network of 13 hospitals, and officials hope it will anchor major development in Largo.
  • One of the federal government’s top consumer watchdogs has roused itself from its torpor and, finally, moved to ban what a leading independent group calls “dangerous infant sleepers and other products that do not align with expert medical recommendations for safe sleep.”
  • Just because myriad drugs and supplements are sold over the counter does not mean these pills are safe. They can pose serious health risks and cause major damage, a prominent Midwestern congressman has reminded by sharing her own near-disaster with a well-known OTC drug. Debbie Dingell, a Michigan Democrat, told the Washington Post that she recently awoke with great pain and a feeling of bloating. Her symptoms were so severe and unrelenting that she called her doctor and was rushed into emergency surgery for a perforated ulcer. She was hospitalized for a week to recuperate. The likely cause for her serious problems, her doctors told her: Her extended taking of high doses of an over-the-counter pain reliever found in many people’s medicine cabinets — Motrin, or ibuprofen.
HERE’S TO A HEALTHY 2021!

Sincerely,

Patrick Malone
Patrick Malone & Associates

Primary Sidebar

Contact Us

Focus Areas

  • Medical Malpractice
  • Birth Injury
  • Auto, Truck & Motorcycle Accidents
  • Brain & Spinal Cord Injuries
  • Defective Products
  • Dangerous Drugs
  • Nursing Home Neglect & Abuse
  • Consumer Rights
  • Accounting & Legal Malpractice

Resources

The Lawsuit Process
  • Free Fact Kit for injury victims
  • FAQs about injuries & the legal process
  • Steps in the legal process
  • Legal deadlines for your lawsuit
  • What to expect from your “independent” medical examination
  • The jury trial system
Medical Resources
  • Patient Safety Tips
  • Health Care Advocates’ Power Kit
  • DC Hospital Rating Map
  • Patient Safety Newsletter
    from Patrick Malone
For Attorneys
  • Books for Attorneys
  • Expert Witness Resources
  • Articles
  • Briefs
  • Closing Arguments in Trial
  • Medical Society Statements on Expert Witness Testimony
  • Cross Examination Transcripts

What Our Clients Say

  • Client reviews on
  • Client reviews on
View more

Patient Safety Blog by Patrick Malone & Associates

  • Communication
  • Medical Malpractice
  • Medications
  • Hospitals
  • Preventive Care
  • Research Studies
  • Accessibility of Health Care
  • Disclosure
  • Primary Care
  • Product Safety
View More Topics

Footer

Our Location

  • PATRICK MALONE & ASSOCIATES, P.C.

    1310 L Street NW
    Suite 800
    Washington, DC 20005

  • Phone: (202) 742-1500
  • Toll Free: (888) 625-6635
  • EMAIL
  • Facebook
  • Twitter
  • Youtube
  • Linkedin

What We Do

  • Brain And Spinal Cord Injuries
  • Medical Malpractice
  • Birth Injury
  • Auto, Truck And Motorcycle Injuries
  • Defective And Dangerous Products
  • Dangerous Drugs
  • Nursing Home Neglect And Abuse
  • Consumer Rights
  • Accounting and Legal Malpractice

Directions

Get Directions

© 2023 Patrick Malone & Associates, P.C. | All Rights Reserved | Legal Notice